Medical Bulletin 13/October/2021

Published On 2021-10-13 13:30 GMT   |   Update On 2021-10-19 12:01 GMT
Advertisement

Here are the top Medical stories of the day

Reused transplanted liver


Dexamethasone may help cancer patients survive longer


Ankle fracture patients at higher risk of venous thromboembolism

Some of the most common and impactful complications of operatively treated ankle fractures include wound necrosis, surgical site infection, malunion, nonunion, and posttraumatic ankle arthritis.

A new study by Dr. Keerat dr MD, MSc, and team reported that there was a 90-day incidence of venous thromboembolism among patients discharged from the Emergency Department (ED) with ankle fractures requiring immobilization was 1.3%.

Advertisement

For more details, check out the full story on the link below:

Ankle Fracture Patients At Higher Risk Of Venous Thromboembolism: Study


Video games can help diabetes and heart patients

Active videogames (AVGs) have been primarily studied in healthy individuals. In order to use the technology in type 1 diabetes mellitus (T1DM) patients, cardiovascular and enjoyment responses should be studied and compared with traditional exercises.

Active video games have similar positive health effects on the body as traditional exercises, such as on a treadmill, finds a new study. The researchers say these games could be used by type 1 diabetics as a more enjoyable way to stay active and manage their condition.

For more details, check out the full story on the link below:

Video Games Can Have Similar Health Benefits To Jogging In Diabetes And Heart Patients


Semaglutide once weekly can help weight loss in obese individuals

Once-weekly semaglutide (2.4 mg) in adjunct with diet and exercise, is effective for weight loss in non-diabetic obese or overweight adults, finds a recent study in the New England Journal of Medicine.

According to WHO, obesity is a global health challenge whose prevalence has nearly tripled worldwide since 1975. Few pharmacologic options further makes the situation even more worse. Semaglutide is an anti-diabetic medicine approved for the treatment of type 2 diabetes.

For more details, check out the full story on the link below:

Semaglutide May Effect Weight Loss Upto 20% In Obese: NEJM

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News